Network that oversees cancer trials in the US needs to be streamlined, says reportBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c3076 (Published 09 June 2010) Cite this as: BMJ 2010;340:c3076
- Susan Mayor
The organisation and funding of clinical trials in cancer in the US needs a complete overhaul to improve their efficiency and prioritisation of research questions and to make better use of new technologies such as biomarkers, warns a report from the Institute of Medicine launched at the American Society of Clinical Oncology annual meeting in Chicago, 4 to 8 June.
The National Cancer Institute’s Clinical Trials Cooperative Group Program has taken the lead in organising clinical trials to explore new and improved cancer treatments for the past 50 years. It comprises 10 groups bringing together more than 3000 institutions, including the Cancer and Leukemia Group B, the Eastern Cooperative Group, and the Southwest Oncology Group, which have made major contributions to improving the treatment of a range of …